Nivolumab vs Pregabalin
Nivolumab vs Pregabalin: Overview
This comparison examines the pharmacological differences between Nivolumab and Pregabalin.
Mechanism of Action
Nivolumab: Fully human anti-PD-1 IgG4 monoclonal antibody restoring T-cell anti-tumor activity.
Pregabalin: Binds alpha-2-delta subunit of voltage-gated calcium channels.
Pharmacokinetics
Half-life: Nivolumab — 27 days; Pregabalin — 6.3 hours.
Chemical Properties
Molecular Formula: Pregabalin — C8H17NO2.
Molecular Weight: Pregabalin — 159.2260 g/mol.
Type: Nivolumab — Antibody; Pregabalin — Small molecule.